Showing 3241-3250 of 5646 results for "".
- Amazon Enters Health-Tracking Space With Halo Wristband, App Debuthttps://modernod.com/news/amazon-enters-health-tracking-space-with-halo-wristband-app-debut/2478213/Amazon introduced Halo on Thursday, a subscription service that uses an app and wristband to monitor an individual’s overall health and wellness, including activity, sleep and body fat, as well as tone of voice to analyze emotional well-being. “We are using Amazo
- AGTC Announces Publication of Preclinical Data that Support the Ongoing Clinical Development of Its XLRP Gene Therapy Programhttps://modernod.com/news/agtc-announces-publication-of-preclinical-data-that-support-the-ongoing-clinical-development-of-its-xlrp-gene-therapy-program/2478200/Applied Genetic Technologies Corporation (AGTC) announced that preclinical data validating the transgene (hRPGRco) that is being evaluated in the company’s ongoing phase 1/2 clinical trial in patients with X-lined retinitis pigmentosa (XLRP) have been published in the July 15, 2020 print issue of
- EU Wraps Up Advanced Talks With Moderna for COVID-19 Vaccine Supply Dealhttps://modernod.com/news/eu-wraps-up-advanced-talks-with-moderna-for-covid-19-vaccine-supply-deal/2478195/The European Commission said Monday that it concluded exploratory talks with Moderna for an initial purchase of 80 million doses of the company’s mRNA vaccine candidate against SARS-CoV-2. The contractual framework would also provide an option for EU member states to purchase an additional
- SIFI Reports Positive Results From 044/si Phase 3 Clinical Trial of Netildex Gelhttps://modernod.com/news/sifi-reports-positive-results-from-044-si-phase-3-clinical-trial-of-netildex-gel/2478196/SIFI has announced the conclusion of a phase 3 clinical trial aimed at demonstrating the noninferiority of Netildex gel administered twice daily (BID) vs. Netildex solution administered four ti
- EU Wraps Up Exploratory Talks With J&J to Secure Coronavirus Vaccinehttps://modernod.com/news/eu-wraps-up-exploratory-talks-with-jj-to-secure-coronavirus-vaccine/2478163/The European Commission said that it concluded exploratory talks with Johnson & Johnson to buy Ad26.COV2.S, the company’s vaccine candidate against COVID-19. Under the potential deal, once a vaccine has shown to be safe and effective against the novel coronavirus, the Commission s
- AAO: Planned Medicare Cuts Deal Heavy Blow to Nation’s Ophthalmologistshttps://modernod.com/news/aao-planned-medicare-cuts-deal-heavy-blow-to-nations-ophthalmologists/2478132/The American Academy of Ophthalmology (AAO) released a statement opposing the Centers for Medicare & Medicaid Services (CMS) proposed annual Physician Fee Schedule and Quality Payment Program
- Some Providers Face Daunting Repayment Deadline for Medicare Advance Loanshttps://modernod.com/news/some-providers-face-daunting-repayment-deadline-for-medicare-advance-loans/2478108/Starting this month, some providers are facing the prospect of their Medicare payments garnished to repay COVID-19 loans, according to a FierceHealthcare
- As Ophthalmology Clinics Reopen, New Questions Aboundhttps://modernod.com/news/as-ophthalmology-clinics-reopen-new-questions-abound/2478093/As the COVID-19 pandemic continues to upend our professional and personal lives, predicting what the future may hold has become an increasingly difficult task. Sumit (Sam) Garg, MD, wrote a commentary for Medscape News discussing what the
- Senate GOP Outlines Next Coronavirus Relief Bill as Deadline for Enhanced Unemployment Benefits Nearshttps://modernod.com/news/senate-gop-outlines-next-coronavirus-relief-bill-as-deadline-for-enhanced-unemployment-benefits-nears/2478090/Senate Republicans outlined their fourth phase of federal coronavirus response efforts, rolling out their legislative package as enhanced unemployment benefits are beginning to expire for millions of Americans who are out of work due to the coronavirus pandemic, accordin
- A Potential New Approach to Combat Drug Resistance in Age-Related Macular Degenerationhttps://modernod.com/news/a-potential-new-approach-to-combat-drug-resistance-in-age-related-macular-degeneration/2478031/An international team of researchers led by Baylor College of Medicine and Houston Methodist has discovered a strategy that can potentially address a major challenge to the current treatment for choroidal neovascularization (CNV), according to a university news release. Anti-vascular endot
